Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited)

v3.20.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) - USD ($)
Common Stock
Additional Paid in Capital
Accumulated Deficit
Total
Balances at beginning at Dec. 31, 2017 $ 1,679 $ 12,361,205 $ (20,284,671) $ (7,921,787)
Balances at beginning (in shares) at Dec. 31, 2017 16,797,744      
Shares issued in private placement, net of costs $ 665 4,031 4,696
Shares issued in private placement, net of costs (in shares) 6,648,586      
Issuance of shares in debt conversion $ 202 4,002,816 4,003,018
Issuance of shares in debt conversion (in shares) 2,017,402      
Reclassification of derivative liability 1,141,995 1,141,995
Purchase and retirement of common stock $ (3,260) (3,260)
Purchase and retirement of common stock (in shares) (32,600,000)      
Effect of merger and recapitalization pursuant to execution of Agreement and Plan of Merger and Reorganization $ 5,760 (18,313) (12,553)
Effect of merger and recapitalization pursuant to execution of Agreement and Plan of Merger and Reorganization (in shares) 57,600,000      
Net loss (12,096,864) (12,096,864)
Balances at ending at Dec. 31, 2018 $ 5,046 17,491,734 (32,381,535) (14,884,755)
Balance, ending (in shares) at Dec. 31, 2018 50,463,732      
Stock-based compensation 938,052 938,052
Shares issued in private placement, net of costs $ 289 6,109,433 6,109,722
Shares issued in private placement, net of costs (in shares) 2,885,600      
Shares issued in exchange for debt $ 580 14,496,291 14,496,871
Shares issued in exchange for debt, shares 5,798,753      
Shares issued for extension of debt $ 12 299,988 300,000
Shares issued for extension of debt, Shares 120,000      
Net loss     (19,390,132) (19,390,132)
Balances at ending at Dec. 31, 2019 $ 5,927 $ 39,335,498 $ (51,771,667) $ (12,430,242)
Balance, ending (in shares) at Dec. 31, 2019 59,268,085